Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that management will present at two investor conferences in June as follows:
|
Conference: |
Jefferies 2017 Global Healthcare Conference |
|||||||
| Date: | Thursday, June 8, 2017 | |||||||
| Time: | 1:30 p.m. Eastern Daylight Time | |||||||
| Location: | Grand Hyatt New York, NYC | |||||||
|
Presenters: |
Scott Tarriff, Chief Executive Officer, and David Pernock, President and Chief Commercial Officer |
|||||||
|
Webcast: |
|
Conference: |
William Blair 37th Annual Growth Stock Conference |
|||||||
| Date: | Wednesday, June 14, 2017 | |||||||
| Time: | 1:20 p.m. Central Daylight Time | |||||||
| Location: | Four Seasons Hotel, Chicago | |||||||
|
Presenters: |
David Pernock, President and Chief Commercial Officer, and David Riggs, Executive Vice President of Administration |
|||||||
|
Webcast: |
||||||||
The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.
Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com